retatrutide type 2 diabetes More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase The power of three: Retatrutide's

Most patients lose 2 to 5 pounds of weight within the first week using MD Weight Loss proven programs

Other drugs in the same group as propranolol also hide these signs of low blood sugar

The brainstem provides another critical site for GLP-1's appetite effects

Betsy Dovec, MD, FACS , says that it's reasonable to wonder if GLP-1 patches will hit the market soon

A Dietitian's Honest Guide Written by Marina Savelyeva, MS, RDN, LD | Medically Reviewed | Updated March 2026 Focus on lean protein, high-fiber vegetables and whole grains, and healthy fats these food groups work alongside GLP-1 medications, not just around them

About this article Cite this article Stoicovy, R.A., Cora, N., Perez, A